SCHEMBL4637629

SCHEMBL4637629

CC(C)c1ccc(S(=O)(=O)c2ccc(F)cc2)cc1S(=O)(=O)NCCC1CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.41
PIK3CB P42338 1/20 0.41
PIK3CG P48736 1/20 0.41
BRD4 O60885 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTR1A P08908 1/20 0.38
DRD2 P14416 1/20 0.38
HTR7 P34969 1/20 0.38
HTR6 P50406 1/20 0.38
ALDH1A1 P00352 3/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CNR2 P34972 6/20 0.36
PKM P14618 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
SFRP1 Q8N474 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
OPRL1 P41146 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616241 0.90 PIK3CD (0.39) PIK3CDPIK3CBPIK3CGBRD4SMN1; SMN2
SCHEMBL4617752 0.90 HTR1A (0.47) HTR1ADRD2HTR7HTR6CNR2
SCHEMBL4617625 0.89 PIK3CD (0.42) PIK3CDPIK3CBPIK3CGBRD4ALDH1A1
SCHEMBL4618273 0.88 CNR2 (0.45) PIK3CDPIK3CBPIK3CGBRD4CNR2
SCHEMBL4617527 0.87 SFRP1 (0.49) PIK3CDPIK3CBPIK3CGBRD4SMN1; SMN2
SCHEMBL6101911 0.85 PIK3CD (0.39) PIK3CDPIK3CBPIK3CGBRD4CNR2
SCHEMBL6101949 0.85 KMT2A (0.39) PIK3CDPIK3CBPIK3CGBRD4HTR7
SCHEMBL4619001 0.83 SFRP1 (0.41) PIK3CDPIK3CBPIK3CGBRD4SMN1; SMN2
SCHEMBL4619031 0.83 BRD3 (0.37) SMN1; SMN2HTR1ADRD2HTR7HTR6
SCHEMBL6103313 0.82 HTR1A (0.42) HTR1ADRD2HTR7HTR6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 PIK3CD 3716/4885PIK3CB 3946/4885PIK3CG 4233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.